Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


Recombinant Nontypeable Genotype II Human Noroviruses in the Americas.

Tohma K, Lepore CJ, Degiuseppe JI, Stupka JA, Saito M, Mayta H, Zimic M, Ford-Siltz LA, Gilman RH, Parra GI.

Emerg Infect Dis. 2020 Jan;26(1):157-159. doi: 10.3201/eid2601.190626.


Population Genomics of GII.4 Noroviruses Reveal Complex Diversification and New Antigenic Sites Involved in the Emergence of Pandemic Strains.

Tohma K, Lepore CJ, Gao Y, Ford-Siltz LA, Parra GI.

mBio. 2019 Sep 24;10(5). pii: e02202-19. doi: 10.1128/mBio.02202-19.


Genomics Analyses of GIV and GVI Noroviruses Reveal the Distinct Clustering of Human and Animal Viruses.

Ford-Siltz LA, Mullis L, Sanad YM, Tohma K, Lepore CJ, Azevedo M, Parra GI.

Viruses. 2019 Mar 1;11(3). pii: E204. doi: 10.3390/v11030204.


Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination.

Wang W, Chen Q, Ford-Siltz LA, Katzelnick LC, Parra GI, Song HS, Vassell R, Weiss CD.

Clin Infect Dis. 2019 May 30;68(12):2067-2078. doi: 10.1093/cid/ciy818.


Phospholipid synthesis fueled by lipid droplets drives the structural development of poliovirus replication organelles.

Viktorova EG, Nchoutmboube JA, Ford-Siltz LA, Iverson E, Belov GA.

PLoS Pathog. 2018 Aug 27;14(8):e1007280. doi: 10.1371/journal.ppat.1007280. eCollection 2018 Aug.


Evolutionary dynamics of non-GII genotype 4 (GII.4) noroviruses reveal limited and independent diversification of variants.

Tohma K, Lepore CJ, Ford-Siltz LA, Parra GI.

J Gen Virol. 2018 Aug;99(8):1027-1035. doi: 10.1099/jgv.0.001088. Epub 2018 Jun 19.


Complete Genome Sequence of a Nontypeable GII Norovirus Detected in Peru.

Tohma K, Saito M, Mayta H, Zimic M, Lepore CJ, Ford-Siltz LA, Gilman RH, Parra GI.

Genome Announc. 2018 Mar 8;6(10). pii: e00095-18. doi: 10.1128/genomeA.00095-18.


Phylogenetic Analyses Suggest that Factors Other Than the Capsid Protein Play a Role in the Epidemic Potential of GII.2 Norovirus.

Tohma K, Lepore CJ, Ford-Siltz LA, Parra GI.

mSphere. 2017 May 17;2(3). pii: e00187-17. doi: 10.1128/mSphereDirect.00187-17. eCollection 2017 May-Jun.


Enterovirus replication: go with the (counter)flow.

Nchoutmboube J, Ford-Siltz LA, Belov GA.

Trends Microbiol. 2015 Apr;23(4):183-4. doi: 10.1016/j.tim.2015.02.008. Epub 2015 Mar 3.


Cell-specific establishment of poliovirus resistance to an inhibitor targeting a cellular protein.

Viktorova EG, Nchoutmboube J, Ford-Siltz LA, Belov GA.

J Virol. 2015 Apr;89(8):4372-86. doi: 10.1128/JVI.00055-15. Epub 2015 Feb 4.


GBF1- and ACBD3-independent recruitment of PI4KIII╬▓ to replication sites by rhinovirus 3A proteins.

Dorobantu CM, Ford-Siltz LA, Sittig SP, Lanke KH, Belov GA, van Kuppeveld FJ, van der Schaar HM.

J Virol. 2015 Feb;89(3):1913-8. doi: 10.1128/JVI.02830-14. Epub 2014 Nov 19.


New small-molecule inhibitors effectively blocking picornavirus replication.

Ford Siltz LA, Viktorova EG, Zhang B, Kouiavskaia D, Dragunsky E, Chumakov K, Isaacs L, Belov GA.

J Virol. 2014 Oct;88(19):11091-107. doi: 10.1128/JVI.01877-14. Epub 2014 Jul 9.


Fluorescent fatty acid analogs as a tool to study development of the picornavirus replication organelles.

Viktorova EG, Ford-Siltz LA, Nchoutmboube J, Belov GA.

J Virol Methods. 2014 May;200:15-21. doi: 10.1016/j.jviromet.2014.01.020. Epub 2014 Feb 3.


Supplemental Content

Loading ...
Support Center